Financial News
All News about Harrow Inc
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_8264.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220809005923/en/1533746/5/Harrow_logo_wTag.jpg)
Harrow Health Announces Second Quarter 2022 Financial Results
August 09, 2022
From Harrow Health, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220727005305/en/1153477/5/HROW_Logo.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/earnings_image_2641.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/earnings_scheduled_1919.png)
![](https://mms.businesswire.com/media/20220624005018/en/1153477/5/HROW_Logo.jpg)
![](https://investorplace.com/wp-content/uploads/2022/04/microcaps.jpg)
![](https://mms.businesswire.com/media/20220505006029/en/1153477/5/HROW_Logo.jpg)
From Harrow Health, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220503006359/en/1153481/5/MELT_logo.jpg)
![](https://mms.businesswire.com/media/20220422005283/en/1153477/5/HROW_Logo.jpg)
![](https://mms.businesswire.com/media/20220420005352/en/1153477/5/HROW_Logo.jpg)
![](https://mms.businesswire.com/media/20220331005238/en/1153477/5/HROW_Logo.jpg)
From Harrow Health, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220224005223/en/1153477/5/HROW_Logo.jpg)
![](https://mms.businesswire.com/media/20220222005440/en/1153477/5/HROW_Logo.jpg)
From Harrow Health, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220214005899/en/1153477/5/HROW_Logo.jpg)
Harrow Health to Present at Aegis Virtual Conference
February 15, 2022
From Harrow Health, Inc.
Via Business Wire
![](https://investorplace.com/wp-content/uploads/2022/01/insider-buying.jpg)
![](https://mms.businesswire.com/media/20220208005530/en/1153477/5/HROW_Logo.jpg)
Harrow Health Publishes Corporate Transparency Report
February 08, 2022
From Harrow Health, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220110005116/en/1153477/5/HROW_Logo.jpg)
From Harrow Health, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20220104005278/en/1153481/5/MELT_logo.jpg)
Melt Pharmaceuticals Submits INDs for MELT‑210 and MELT-400 to FDA
January 04, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20211220005121/en/1153477/5/HROW_Logo.jpg)
Harrow Health Acquires U.S. Commercial Rights to Four Branded Eye Drops
December 20, 2021
From Harrow Health, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20211213005282/en/1153477/5/HROW_Logo.jpg)
Harrow Health Added to the Nasdaq Biotechnology Index
December 13, 2021
From Harrow Health, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/medicine-1309148_1920_391.jpg)
![](https://mms.businesswire.com/media/20211109006451/en/1153477/5/HROW_Logo.jpg)
Harrow Health Announces Third Quarter 2021 Financial Results
November 09, 2021
From Harrow Health, Inc.
Via Business Wire
![](https://mms.businesswire.com/media/20211025005018/en/1153477/5/HROW_Logo.jpg)
![](https://mms.businesswire.com/media/20210902005101/en/1153481/5/MELT_logo.jpg)
From Harrow Health, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_1524.png)
![](https://mms.businesswire.com/media/20210818005087/en/1153477/5/HROW_Logo.jpg)
![](https://mms.businesswire.com/media/20210812005137/en/1153477/5/HROW_Logo.jpg)
From Harrow Health, Inc.
Via Business Wire
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/sites/all/themes/bz2/images/bz-icon.png)
![](https://mms.businesswire.com/media/20210810005917/en/1153477/5/HROW_Logo.jpg)
Harrow Health Announces Second Quarter 2021 Financial Results
August 10, 2021
From Harrow Health, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.